VR Logo

Predictive Oncology Inc. (POAI) download report


Healthcare | Medical Devices & Equipment

Predictive Oncology Inc. (POAI) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States.

IPO Date: 29-Jan-2018

Chairman & CEO: Mr. J. Melville Engle

CFO & Sec.: Mr. Robert L. Myers

Listing: NASDAQ: POAI

Country: United States

Headquarters: Eagan, MN

Website: https://www.predictive-oncology.com

Key Facts

Market cap: $33.30 Mln

Revenue (TTM): $1.45 Mln

Earnings (TTM): $-19.14 Mln

Cash: $25.12 Mln

Total Debt: $0.70 Mln

Insider's Holding: 3.91%

Liquidity: Low

52 Week range: $0.25 - 1.47

Shares outstanding: 78,159,696

10 Years Aggregate:

  • CFO: $-63.23 Mln
  • EBITDA: $-113.24 Mln
  • Net Profit: $-117.74 Mln

Stock Performance

Time Period Predictive Oncology (POAI) S&P BSE Sensex* S&P Small-Cap 600*
YTD-56.80-8.85-19.22
1 month8.24-3.25-9.34
3 months-61.20-8.36-14.58
1 Year-62.271.05-17.64
3 Years-61.9710.465.91
5 Years-50.4711.475.64
10 Years-54.9011.7810.10
As on 29-Jun-2022 *As on 30-Jun-2022
Year Predictive Oncology (POAI) S&P Small-Cap 600 S&P BSE Sensex
202129.9825.2721.99
2020-71.949.5715.75
2019-57.8420.8614.38
2018-38.54-9.705.87
2017-63.9311.7327.91
2016-96.1924.741.95
2015-54.77-3.36-5.03